The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Tumor Ablation Market Over The Period 2026–2030?
The tumor ablation market has demonstrated rapid growth in recent years. Its size is expected to expand from $1.62 billion in 2025 to $1.81 billion in 2026, registering a compound annual growth rate (CAGR) of 11.8%. The historical expansion of this market can be ascribed to several factors, including a rising incidence of solid tumors, the greater adoption of minimally invasive cancer treatments, the establishment of more oncology care centers, the availability of advanced imaging guidance, and improved clinical outcomes associated with ablation therapies.
The tumor ablation market size is anticipated to undergo significant expansion over the next few years. It is forecast to grow to $2.69 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.4%. This projected growth during the forecast period can be attributed to a heightened demand for targeted cancer therapies, rising investments in precision oncology solutions, the proliferation of outpatient cancer treatment facilities, the integration of AI-based treatment planning, and an increasing focus on patient-centric cancer care. Key trends anticipated in the forecast period include a greater adoption of minimally invasive ablation procedures, an increasing use of image-guided ablation technologies, a growing preference for thermal ablation techniques, the expansion of outpatient tumor treatment settings, and an intensified concentration on precision oncology.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17283&type=smp
Which Major Factors Are Driving The Expansion Of The Tumor Ablation Market?
The expanding implementation of minimally invasive techniques is projected to boost the tumor ablation market’s expansion. Minimally invasive interventions, which encompass robot-assisted surgeries, are surgical approaches characterized by small or absent incisions, leading to quicker recovery, fewer complications, and less post-operative discomfort. This transition is fueled by patients’ desire for expedited recovery, innovations in surgical robotics, and enhanced precision in imaging-guided treatments. Tumor ablation technologies, such as radiofrequency, microwave, and cryoablation, support this trend by precisely targeting cancerous tissue while safeguarding surrounding healthy areas. For instance, data from June 2024, provided by the American Society of Plastic Surgeons, a US-based non-profit organization, indicated a 7% increase in minimally invasive procedures in 2023, surpassing the growth rate of overall surgical procedures by 2%. Specifically, hand surgeries like carpal tunnel, arthritis, and trigger finger reached 207,887 procedures, marking a 2% increase from 2022. Consequently, the expanding utilization of minimally invasive procedures is a key factor driving the growth of the tumor ablation market.
How Is The Tumor Ablation Market Divided Into Its Major Segments?
The tumor ablation market covered in this report is segmented –
1) By Type: Thermal Ablation, Chemical Ablation
2) By Types Of Treatment: Percutaneous, Laparoscopic, Surgical
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Cancer
4) By End Users: Hospitals, Oncology Centers, Other End Users
Subsegments:
1) By Thermal Ablation: Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cryoablation, Laser Ablation, High-Intensity Focused Ultrasound (HIFU)
2) By Chemical Ablation: Ethanol Ablation, Acetic Acid Ablation, Transarterial Chemoembolization
How Are Trends Transforming The Tumor Ablation Market Landscape?
Leading companies in the tumor ablation market are focused on developing innovative products, such as advanced bone tumor ablation systems, to improve treatment efficacy, enhance patient outcomes, and broaden the spectrum of treatable tumors. A bone tumor ablation system represents a specialized medical device engineered for the minimally invasive treatment of bone tumors. For instance, in March 2024, Medtronic plc, an Ireland-based medical device company, secured U.S. Food and Drug Administration (FDA) 510(k) clearance for its OsteoCool 2.bone tumor ablation system. This updated system is designed to address painful bone metastases and benign bone tumors like osteoid osteoma. The OsteoCool 2.0 facilitates the simultaneous operation of four internally cooled probes, enabling medical professionals to ablate two vertebral bodies concurrently or establish larger ablation zones in extra-spinal applications. It delivers 20W per channel, which is more than double the power of the Stryker OptaBlate bone tumor ablation system.
Who Are The Prominent Organizations Shaping The Tumor Ablation Market?
Major companies operating in the tumor ablation market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Varian Medical Systems Inc., Merit Medical Systems Inc., Accuray Incorporated, AngioDynamics Inc., EDAP TMS S.A., NeuWave Medical Inc., Mirabilis Medical Inc., STARMed Co. Ltd., Profound Medical Corp., RF Medical Co. Ltd., IceCure Medical Ltd., MedWaves Inc., Chongqing Haifu Medical Technology Co. Ltd., Hologic Inc., Johnson & Johnson MedTech
Read the full tumor ablation market report here:
https://www.thebusinessresearchcompany.com/report/tumor-ablation-global-market-report
Which Region Currently Holds The Largest Share Of The Tumor Ablation Market?
North America was the largest region in the tumor ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Tumor Ablation Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=17283&type=smp
Browse Through More Reports Similar to the Global Tumor Ablation Market 2026, By The Business Research Company
Tumor Ablation Therapy Devices Market Report 2026
Oncology Ablation Market Report 2026
https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report
Ablation Technology Market Report 2026
https://www.thebusinessresearchcompany.com/report/ablation-technology-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model